Thrombocytopenia
"Thrombocytopenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subnormal level of BLOOD PLATELETS.
Descriptor ID |
D013921
|
MeSH Number(s) |
C15.378.140.855
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thrombocytopenia".
Below are MeSH descriptors whose meaning is more specific than "Thrombocytopenia".
This graph shows the total number of publications written about "Thrombocytopenia" by people in this website by year, and whether "Thrombocytopenia" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1980 | 0 | 1 | 1 | 1981 | 0 | 2 | 2 | 1984 | 1 | 0 | 1 | 1985 | 0 | 2 | 2 | 1986 | 1 | 2 | 3 | 1987 | 1 | 0 | 1 | 1989 | 2 | 0 | 2 | 1990 | 0 | 2 | 2 | 1991 | 2 | 0 | 2 | 1993 | 1 | 0 | 1 | 1994 | 0 | 5 | 5 | 1995 | 0 | 3 | 3 | 1996 | 0 | 2 | 2 | 1997 | 0 | 1 | 1 | 1998 | 1 | 2 | 3 | 2000 | 0 | 2 | 2 | 2001 | 0 | 2 | 2 | 2002 | 2 | 2 | 4 | 2003 | 0 | 2 | 2 | 2004 | 0 | 3 | 3 | 2005 | 2 | 2 | 4 | 2006 | 2 | 2 | 4 | 2007 | 0 | 4 | 4 | 2008 | 2 | 2 | 4 | 2009 | 1 | 5 | 6 | 2010 | 2 | 1 | 3 | 2011 | 0 | 1 | 1 | 2012 | 1 | 1 | 2 | 2013 | 0 | 2 | 2 | 2014 | 1 | 2 | 3 | 2015 | 2 | 1 | 3 | 2016 | 1 | 2 | 3 | 2017 | 2 | 2 | 4 | 2018 | 2 | 1 | 3 | 2019 | 0 | 1 | 1 | 2020 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Thrombocytopenia" by people in Profiles.
-
Pollyea DA, Pratz K, Letai A, Jonas BA, Wei AH, Pullarkat V, Konopleva M, Thirman MJ, Arellano M, Becker PS, Chyla B, Hong WJ, Jiang Q, Potluri J, DiNardo CD. Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study. Am J Hematol. 2021 02 01; 96(2):208-217.
-
DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J, Pratz KW. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N Engl J Med. 2020 08 13; 383(7):617-629.
-
Mina A, van Besien K, Platanias LC. Hematological manifestations of COVID-19. Leuk Lymphoma. 2020 12; 61(12):2790-2798.
-
Eklund JE, Shah SH, Rubin DS, Mehta AI, Minev EM, Lee HH, Roth S. Incidence of and factors associated with acute kidney injury after scoliosis surgery in pediatric patients. Spine Deform. 2020 10; 8(5):991-999.
-
Gavriatopoulou M, Chari A, Chen C, Bahlis N, Vogl DT, Jakubowiak A, Dingli D, Cornell RF, Hofmeister CC, Siegel D, Berdeja JG, Reece D, White D, Lentzsch S, Gasparetto C, Huff CA, Jagannath S, Baz R, Nooka AK, Richter J, Abonour R, Parker TL, Yee AJ, Moreau P, Lonial S, Tuchman S, Weisel KC, Mohty M, Choquet S, Unger TJ, Li K, Chai Y, Li L, Shah J, Shacham S, Kauffman MG, Dimopoulos MA. Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. Leukemia. 2020 09; 34(9):2430-2440.
-
Garcia-Manero G, Roboz G, Walsh K, Kantarjian H, Ritchie E, Kropf P, O'Connell C, Tibes R, Lunin S, Rosenblat T, Yee K, Stock W, Griffiths E, Mace J, Podoltsev N, Berdeja J, Jabbour E, Issa JJ, Hao Y, Keer HN, Azab M, Savona MR. Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial. Lancet Haematol. 2019 Jun; 6(6):e317-e327.
-
Cimeno A, Barth RN, LaMattina JC. Advances in liver xenotransplantation. Curr Opin Organ Transplant. 2018 12; 23(6):615-620.
-
Cho JH, Parilla M, Treml A, Wool GD. Plasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: A challenging case and a survey of the field. J Clin Apher. 2019 Feb; 34(1):64-72.
-
Gray HJ, Bell-McGuinn K, Fleming GF, Cristea M, Xiong H, Sullivan D, Luo Y, McKee MD, Munasinghe W, Martin LP. Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies. Gynecol Oncol. 2018 03; 148(3):507-514.
-
Cimeno A, Hassanein W, French BM, Powell JM, Burdorf L, Goloubeva O, Cheng X, Parsell DM, Ramsoondar J, Kuravi K, Vaught T, Uluer MC, Redding E, O'Neill N, Laird C, Hershfeld A, Tatarov I, Thomas K, Ayares D, Azimzadeh AM, Pierson RN, Barth RN, LaMattina JC. N-glycolylneuraminic acid knockout reduces erythrocyte sequestration and thromboxane elaboration in an ex vivo pig-to-human xenoperfusion model. Xenotransplantation. 2017 11; 24(6).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|